FL104

CAS No. 885672-81-1

FL104( —— )

Catalog No. M34257 CAS No. 885672-81-1

FL104 is a potent agonist of small-molecule urotensin II receptor, pEC50= 7.11.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 333 In Stock
5MG 273 In Stock
10MG 372 In Stock
25MG 563 In Stock
50MG 742 In Stock
100MG 977 In Stock
200MG 1293 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    FL104
  • Note
    Research use only, not for human use.
  • Brief Description
    FL104 is a potent agonist of small-molecule urotensin II receptor, pEC50= 7.11.
  • Description
    FL104 is a potent agonist of small-molecule urotensin II receptor, pEC50= 7.11.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    GPR
  • Recptor
    GPR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    885672-81-1
  • Formula Weight
    392.92
  • Molecular Formula
    C24H25ClN2O
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(NC(=O)C1=CC=C(C=C1)C2=CC=CC=C2)(CCN(C)C)C3=CC=C(Cl)C=C3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Azathioprine

    Azathioprine is an immunosuppressive drug, inhibiting purine synthesis and GTP-binding protein Rac1 activation, used in the treatment of organ transplantation and autoimmune diseases.

  • GPR81 agonist 1

    GPR81 agonist 1 is a potent and selective GPR81 agonist with high affinity for human and mouse GPR81, inhibiting lipolysis of differentiated 3T3-L1 adipocytes, improving insulin sensitivity and glycaemic control in mouse models of insulin resistance and diabetes, and can be used in the study of diabetes and obesity.

  • CID 2745687

    CID 2745687 is a GPR35 antagonist that inhibited the effects at human GPR35 of cromolyn disodium and zaprinast, two agonists that share an overlapping binding site.